Name | N-Hydroxy-2-[methyl({2-[6-(methylamino)-3-pyridinyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl}methyl)amino]-5-pyrimidinecarboxamide |
---|---|
Synonyms |
N-Hydroxy-2-[methyl({2-[6-(methylamino)-3-pyridinyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl}methyl)amino]-5-pyrimidinecarboxamide
5-Pyrimidinecarboxamide, N-hydroxy-2-[methyl[[2-[6-(methylamino)-3-pyridinyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]amino]- CUDC-908 PI3Kα inhibitor 1 BEBT-908 |
Description | PI3Kα inhibitor 1 is a selective PI3Kα inhibitor extracted from patent US/20120088764A1, Compound 243, has an IC50<0.1 μM, PI3Kα inhibitor 1 also inhibits HDAC (0.1 μM≤IC50≤1 μM) . |
---|---|
Related Catalog | |
Target |
PI3Kα:0.1 μM (IC50) HDAC:0.1 μM (IC50) |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C23H25N9O3S |
Molecular Weight | 507.568 |
Exact Mass | 507.180115 |
LogP | 2.31 |
Index of Refraction | 1.728 |